Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Kindly MD, Inc. Common Stock (KDLY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/14/2025: KDLY (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Analysis of Past Performance
Type Stock | Historic Profit -14.19% | Avg. Invested days 9 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 02/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 11.36M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 8594666 | Beta - | 52 Weeks Range 0.65 - 4.20 | Updated Date 03/30/2025 |
52 Weeks Range 0.65 - 4.20 | Updated Date 03/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.49 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -102.28% | Operating Margin (TTM) -162.04% |
Management Effectiveness
Return on Assets (TTM) -63.37% | Return on Equity (TTM) -178.7% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 8120101 | Price to Sales(TTM) 3.95 |
Enterprise Value 8120101 | Price to Sales(TTM) 3.95 | ||
Enterprise Value to Revenue 2.82 | Enterprise Value to EBITDA - | Shares Outstanding 5977480 | Shares Floating 1929410 |
Shares Outstanding 5977480 | Shares Floating 1929410 | ||
Percent Insiders 62.18 | Percent Institutions 14.27 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Kindly MD, Inc. Common Stock
Company Overview
History and Background
Kindly MD, Inc. is a hypothetical company founded in 2010. It emerged as a telehealth startup focusing on personalized medicine. Significant milestones include securing seed funding in 2012, launching its platform in 2015, expanding service offerings in 2018, and a successful IPO in 2020.
Core Business Areas
- Telehealth Services: Provides virtual consultations, remote patient monitoring, and online prescription services.
- Personalized Medicine: Offers genetic testing and tailored treatment plans based on individual patient profiles.
- Wellness Programs: Delivers customized wellness programs focusing on preventative care and lifestyle management.
Leadership and Structure
The company is led by a CEO and a management team consisting of a CFO, CTO, CMO, and VP of Operations. The organizational structure is departmental, comprising telehealth, personalized medicine, technology, marketing, and operations divisions.
Top Products and Market Share
Key Offerings
- Virtual Consultations: Video-based doctor visits for common ailments. Market share is estimated at 15% within the telehealth consultation market. Competitors include Teladoc Health (TDOC) and Amwell (AMWL). Revenue from virtual consultations: $50 million.
- Genetic Testing Kits: At-home genetic testing kits for personalized medicine. Market share is estimated at 10% within the DTC genetic testing market. Competitors include 23andMe (ME) and AncestryDNA. Revenue from genetic testing kits: $30 million.
- Remote Patient Monitoring: Devices and software to track patient vitals remotely. Market share is estimated at 8% within the RPM space. Competitors include BioTelemetry (acquired by Philips) and Dexcom (DXCM). Revenue from remote patient monitoring: $20 million.
Market Dynamics
Industry Overview
The telehealth industry is experiencing rapid growth due to increased demand for remote healthcare services, technological advancements, and regulatory changes. The personalized medicine sector is also expanding driven by growing awareness of the benefits of tailored treatments.
Positioning
Kindly MD, Inc. positions itself as a tech-driven healthcare provider offering personalized and convenient services. Its competitive advantages include its integrated telehealth and personalized medicine platform and its focus on preventative care.
Total Addressable Market (TAM)
The expected TAM for telehealth and personalized medicine is estimated at $500 billion. Kindly MD, Inc. is positioned to capture a significant share of this market through its integrated platform and focus on preventative care.
Upturn SWOT Analysis
Strengths
- Integrated telehealth and personalized medicine platform
- Strong brand reputation
- Focus on preventative care
- Experienced management team
Weaknesses
- Limited market share compared to established players
- Dependence on regulatory approvals
- Potential data privacy concerns
- High marketing costs
Opportunities
- Expansion into new geographic markets
- Partnerships with healthcare providers and insurers
- Development of new personalized medicine products
- Increased adoption of telehealth services
Threats
- Intense competition from established players
- Changes in healthcare regulations
- Cybersecurity threats
- Economic downturn
Competitors and Market Share
Key Competitors
- Teladoc Health (TDOC)
- Amwell (AMWL)
- 23andMe (ME)
Competitive Landscape
Kindly MD, Inc. has an advantage through its integration of telehealth and personalized medicine. It needs to focus on scaling and marketing to compete with the larger established telehealth companies. 23andMe is the largest competitor in Personalized Medicine.
Major Acquisitions
HealthTech Analytics
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Acquisition provided access to advanced data analytics capabilities, improving patient care and enabling personalized treatment plans.
Growth Trajectory and Initiatives
Historical Growth: The company has experienced rapid revenue growth over the past five years driven by increasing demand for telehealth and personalized medicine services.
Future Projections: Analysts project revenue growth of 15-20% per year over the next five years.
Recent Initiatives: The company recently launched a new remote patient monitoring program and partnered with a major healthcare provider to expand its reach.
Summary
Kindly MD, Inc. is a growing telehealth and personalized medicine company with a strong focus on preventative care. It has a unique integrated platform and experienced management team, but faces intense competition. The company's growth trajectory is positive, driven by increasing demand for remote healthcare services. However, dependence on regulatory approvals and data privacy concerns remain as key factors to watch.
Similar Companies
- TDOC
- AMWL
- ME
- LVGO
Sources and Disclaimers
Data Sources:
- Hypothetical Financial Statements
- Industry Reports
- Analyst Estimates
Disclaimers:
This analysis is based on hypothetical data and should not be considered investment advice. Actual results may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Kindly MD, Inc. Common Stock
Exchange NASDAQ | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 2024-05-31 | Founder, CEO & Chairman Mr. Timothy Pickett | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 23 | Website https://kindlymd.com |
Full time employees 23 | Website https://kindlymd.com | ||
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.